Skip to main content

Table 1 Clinical and demographic characteristics of the patients

From: Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study

Characteristic Patients with RA RA control group
Number of patients 57 55
Mean age, years (range) 56 (28–83) 63 (30–83)
Sex (F/M) 53/4 45/10
Disease duration, years (range) 8 (1–27) 6 (1–25)
Adalimumab treatment, n 57 0
Concomitant medications:   
   NSAID 48 34
   Corticosteroids 42 30
   Methotrexate 57 55
   Other 6 0
  1. NSAID, non-steroidal anti-inflammatory drugs; RA, rheumatoid arthritis.